ORY.MC Gross Margin

The Gross Margin of Oryzon Genomics SA (ORY.MC) is -4700.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ORY.MC Gross Margin - Historical Value

Date	Value
2024-12-31	-4700.00%
2023-12-31	-4700.00%
2022-12-31	-216.22%
2021-12-31	50.12%

ORY.MC Gross Margin - Peers Comparison

Ticker	Name	Value
MDXH.BR	MDxHealth SA	51.74%
NANOV.OL	Nordic Nanovector ASA	7775.20%
PCIB.OL	PCI Biotech Holding ASA	100.00%
SANION.ST	Saniona AB	85.03%
SCLP.L	Scancell Holdings PLC	90.13%
BINV.ST	BioInvent International AB	42.37%
GRF.MC	Grifols SA	38.75%
HPHA.DE	Heidelberg Pharma AG	74.01%
PHM.MC	Pharma Mar SA	95.32%
ETX.L	E-Therapeutics PLC	100.00%
EGTX.ST	Egetis Therapeutics AB (publ)	74.84%
IKM.MC	1nkemia IUCT Group SA	227.85%
POXEL.PA	Poxel SA	0.05%
ALBPS.PA	Biophytis SA	7775.20%
ADL.MC	ADL Bionatur Solutions SA	48.22%
BVXP.L	Bioventix PLC	93.20%
DMYD B.ST	Diamyd Medical AB	-10161.54%
FARN.L	Faron Pharmaceuticals Oy	95.19%
MDG1.DE	Medigene AG	72.77%
TILS.L	Tiziana Life Sciences PLC	63.16%
XBRANE.ST	Xbrane Biopharma AB	90.83%
ABVX.PA	Abivax SA	-19700.00%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
ALSEN.PA	Sensorion SA	7775.20%
VSC.DE	4Sc AG	97.20%
ALQGC.PA	Quantum Genomics SA	-14205.07%
BGBIO.OL	Bergenbio ASA	100.00%
MAB.WA	Mabion SA	75.54%
OSE.PA	OSE Immunotherapeutics SA	100.00%
OXUR.BR	Oxurion NV	-1333.33%
VVY.AS	Vivoryon Therapeutics NV	85.42%
BIO.MC	Biosearch SA	39.64%